Chinese Journal of Pharmacovigilance ›› 2014, Vol. 11 ›› Issue (6): 347-350.

Previous Articles     Next Articles

Literature Analysis of 53 Reports of Drug-induced Interstitial Pneumonia

HU Mei-hui1, SUN An-xiu2, *   

  1. 1Medical Academy of Yangzhou University, Jiangsu Yangzhou 22500, China;
    2Department of Pharmacy, First People's Hospital of Yangzhou, Jiangsu Yangzhou 22500, China
  • Received:2013-08-15 Revised:2016-02-03 Online:2014-06-08 Published:2016-03-02

Abstract: ObjectiveTo study the drugs leading to interstitial pneumonia and analyze their clinical characteristics. MethodsWe searched the literatures from 1994 to 2013 by key words of "interstitial pneumonia" in China Digital Library, China National Knowledge Infrastructure, Wanfang Database, and summarized them. ResultsA total of 74 relevant articles were identified, which reported 53 cases of drug-induced interstitial neumonia, involving 15 kinds of drugs. The drugs included gefitinib(15), rituximab(9), leflunomide(8), amiodarone(8), erlotinib(5), interferon(2), 5-fluorouracil(1), granulocyte colony-stimulating factor(1), gemcitabine(1), carmustine(1), measles vaccine(1), paraquat(1), et al.The result showed that 53 cases contained 17 cases(33.33%) cured, 19 cases(37.26%) improved , 15 cases(29.41%) died and 2 cases unclear. ConclusionThe clinical manifestations of interstitial pneumonia induced by drugs were similar, but the pathogenesis was unknown. The drugs leading to higher incidence were gefitinib, rituximab,leflunomide, amiodarone and erlotinib.

Key words: drug, interstitial pneumonia, adverse reaction

CLC Number: